UCB

About UCB

UCB is a global biopharmaceutical company headquartered in the UK, dedicated to transforming the lives of people with severe diseases. With a strong focus on neurology and immunology, UCB aims to develop innovative therapies that address unmet medical needs.

Founded in 1928, UCB has a rich history of scientific research and development. The company invests heavily in R&D, collaborating with healthcare professionals and academic institutions to advance its pipeline of novel treatments.

UCB’s mission is to create value for patients by delivering solutions that improve their quality of life. The company is committed to sustainability and ethical practices, ensuring that its operations have a positive impact on society and the environment.

• Core Areas: Neurology, Immunology
• Headquarters: UK
• Employee Count: Approximately 7,000 globally

UCB’s vision is to be a leader in the biopharmaceutical industry, recognized for its commitment to innovation and patient-centric approaches. The company strives to foster a culture of collaboration and inclusivity, empowering its employees to contribute to meaningful advancements in healthcare.

Through strategic partnerships and a robust pipeline, UCB continues to expand its reach and impact in the global market. The company is dedicated to addressing the challenges faced by patients and healthcare providers, ensuring that its therapies are accessible and effective.